Later investigations confirmed increased protein levels of p53 and p21 in other human bladder cancer cells (TSGH8301) treated with EA, which the authors attributed to the subsequent arrest of the cell cycle at the G0/G1 phase [60]. This evidence concerns the gene CDKN1A and urinary bladder carcinoma.